Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Profit or loss [abstract]      
Revenues $ 2,318 $ 5,014 $ 463
Cost of revenues 1,879 1,659 48
Gross Profit 439 3,355 415
Operating expenses:      
Research and development, net 4,414 3,877 3,906
General, administrative and marketing 3,656 3,723 2,466
Total operating loss 7,631 4,245 5,957
Financial expenses 3,303 2,180 47
Exchange differences 230 (176) 47
Financial expenses, net 3,533 2,004 94
Loss for the period 11,164 6,249 6,051
Other comprehensive loss:      
Currency translation differences 557 (205)
Total comprehensive loss for the period $ 11,164 $ 6,806 $ 5,846
Basic and diluted loss per ordinary share $ 2.23 $ 1.43 $ 2.27
Weighted average number of shares outstanding used in computation of basic and diluted 4,986,381 4,384,585 2,663,741